Commentary on risk factors for first and subsequent cardiovascular disease events in type 1 diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study

Cardiovascular disease in patients with type 2 diabetes

“…There is no debate about whether glycemic control reduces the risk of microvascular complications 1 . However, there is limited clinical evidence that glycemic control reduces cardiovascular disease 2 , 3 , 4 . One in three type 2 diabetes patients has cardiovascular disease, which is the leading cause of death 5 , 6 .…”